Maze Therapeutics (NASDAQ:MAZE) is advancing a genetics-driven approach to drug development, using human genetic analyses to identify gene variants linked to disease and then applying those insights ...
On February 12, 2026, NewcelX announced a peer-reviewed review article in Clinical Drug Investigation analyzing Mazindol immediate-release/sustained-release (IR/SR), highlighting a 50-year ...
QuantumScape Corporation is progressing steadily toward commercialization, transitioning from high-risk speculation to tangible manufacturing milestones. Click for this QS stock update.
AZoLifeSciences on MSN
Single-cell atlas reveals how melanoma evades the immune system
Integrative analysis of immune ecotypes in skin cancers highlights metabolic reprogramming and macrophage polarization as key ...
In some ways, data and its quality can seem strange to people used to assessing the quality of software. There’s often no observable behaviour to check and little in the way of structure to help you ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results